Given the interaction between NF-κB and p53 [13, 14], and that chronic inflammation (i.e., continuous NF-κB activation) is associated with cancer development (i.e., through p53 inactivation), we investigated a potential link between the anti-inflammatory molecule Del-1 and the tumor suppressor p53. Here, TP53 is linked to cancer.